Abstract
Citations & impact
Impact metrics
Article citations
Understanding immune checkpoints and PD-1/PD-L1-mediated immune resistance towards tumour immunotherapy.
3 Biotech, 13(12):411, 21 Nov 2023
Cited by: 0 articles | PMID: 37997595
Review
Potential predictors of immunotherapy in small cell lung cancer.
Pathol Oncol Res, 29:1611086, 03 May 2023
Cited by: 0 articles | PMID: 37206058 | PMCID: PMC10191143
Review Free full text in Europe PMC
New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review).
Int J Oncol, 63(1):86, 16 Jun 2023
Cited by: 3 articles | PMID: 37326100 | PMCID: PMC10308343
Review Free full text in Europe PMC
Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review.
Biomedicines, 11(6):1720, 15 Jun 2023
Cited by: 1 article | PMID: 37371815 | PMCID: PMC10296250
Review Free full text in Europe PMC
TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment.
Front Oncol, 13:1060112, 17 Feb 2023
Cited by: 2 articles | PMID: 36874131 | PMCID: PMC9982004
Review Free full text in Europe PMC
Go to all (79) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Clin Ther, 37(4):764-782, 29 Mar 2015
Cited by: 303 articles | PMID: 25823918 | PMCID: PMC4497957
Review Free full text in Europe PMC
Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies.
Int Immunol, 27(1):39-46, 16 Oct 2014
Cited by: 181 articles | PMID: 25323844
Review
Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy.
Expert Opin Biol Ther, 13(6):847-861, 19 Feb 2013
Cited by: 77 articles | PMID: 23421934
Review
Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer.
Semin Oncol, 42 Suppl 2:S11-8, 11 Sep 2015
Cited by: 38 articles | PMID: 26477470
Review
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
Curr Opin Immunol, 33:23-35, 23 Jan 2015
Cited by: 191 articles | PMID: 25621841
Review